Dental status of the patients with maxillofacial tumours


Cite item

Full Text

Abstract

Dental status including hygine tipes of the oral cavity, which also help correct choice of method of treatment. The level of mineralized tissues, caries, condition of the periodontal soft tissue. All in complex and taken separately present about dental status. Level of the hygine and the Level and quality of individual oral hygiene, often determine not only the amount of dental care, but can be a distant prognosis about the results of the treatment.

About the authors

Ekaterina Vladimirovna Kochurova

I.M. Sechenov First Moscow State Medical University

Email: evkochurova@mail.ru
119991, Moscow, Russian Federation

S. V Kozlov

I.M. Sechenov First Moscow State Medical University

119991, Moscow, Russian Federation

Yu. A Medvedev

I.M. Sechenov First Moscow State Medical University

119991, Moscow, Russian Federation

V. N Nikolenko

M.V. Lomonosov Moscow State University

Факультет фундаментальной медицины 119192, Moscow, Russian Federation

E. M Basin

I.M. Sechenov First Moscow State Medical University

119991, Moscow, Russian Federation

P. S Petruk

I.M. Sechenov First Moscow State Medical University

119991, Moscow, Russian Federation

References

  1. Meurman J.H. Infectious and dietary risk factors of oral cancer. Oral Oncol. 2010; 46(6): 411-3.
  2. Pande P., Soni S., Kaur J., Agarwal S., Mathur M., Shukla N.K., Ralhan R. Prognostic factors in betel and tobacco related oral cancer. Oral Oncol. 2002; 38(5): 491-9.
  3. Чиссов В.А., Старинский В.В., Петрова Г.В. Злокачественные новообразования в России в 2011 году. М.: ФГБУ «МНИОИ им. П.А. Герцена» Минздрава России; 2013.
  4. Fedele S. Diagnostic aids in the screening of oral cancer. Head Neck Oncol. 2009; 30: 1-5.
  5. Zakzerwska J.M., Hindle I., Speight P.M. Practical considerations for the establishment of an oral cancer screening programme. Commun. Dent. Health. 1993; 10(1): 79-85.
  6. Christian D.C. Computer-assisted analysis of oral brush biopsies at an oral cancer screening program. J. Am. Dent. Assoc. 2002; 133: 357-62.
  7. Mehrotra R., Hullmann M., Smeets R., Reichert T.E., Driemel O. Oral cytology revisited. J. Oral Pathol. Med. 2009; 38: 161-6.
  8. Каприн А.Д., Старинский В.В., Петрова Г.В. Состояние онкологической помощи населению России в 2013 году. М.: ФГБУ «МНИОИ им. П.А. Герцена» Минздрава России; 2014.
  9. Давыдов М.И., Аксель Е.М. Статистика злокачественных новообразований в России и странах СНГ в 2012 г. М.: ГУ РОНЦ им. Н.Н. Блохина РАМН, 2014.
  10. Petersen P.E. Oral cancer prevention and control the approach of the World Health Organization. Oral Oncol. 2009; 45(4-5): 454-60.
  11. Onofre M.A., Sposto M.R., Navarro C.M. Reliability of toluidine application in the detection of oral epithelial dysplasia and in situ and invasive squamous cell carcinomas. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 2001; 91: 535-40.
  12. Zhang L., Williams M., Poh C.F. et al. Toluidine blue staining identifies high-risk primary oral premalignant lesions with poor outcome. Cancer Res. 2005; 65: 8017-21.
  13. Guneri P., Epstein J.B., Ergun S. et al. Toluidine blue color perception in identification of oral mucosal lesions. Clin. Oral Investig. 2011; 15(3): 337-45.
  14. Seoane Leston J., Diz Dios P. Diagnostic clinical aids in oral cancer. Oral Oncol. 2010; 46(6): 418-22.
  15. Kerr A.R., Sirois D.A., Epstein J.B. Clinical evaluation of chemiluminescentlighting:an adjunct for oral mucosal examinations. J. Clin. Dent. 2006; 17: 59-63.
  16. Epstein J.B., Silverman S.Jr., Epstein J.D., Lonky S.A., Bride M.A. Analysis of oral lesion biopsies identified and evaluated by visual examination, chemiluminescence and tolouidine blue. Oral Oncol. 2008; 44: 538-44.
  17. Onizawa K., Saginoya H., Furuya Y., Yoshida H. Fluorescence photography as a diagnostic method for oral cancer. Cancer Lett. 1996; 108: 61-6.
  18. Malamud D. Dental Clinics of North America. 2011; 55(1): 159-78.
  19. Николенко В.Н., Козлов С.В., Кочурова Е.В. Способ качественной экспресс-диагностики злокачественных новообразований околоушной слюнной железы по содержанию биомаркеров в плазме крови и в ротовой жидкости пациента /Патент RU 2519101 C1 (Роспатент) “Изобретения. Полезные модели" № 16.
  20. Николенко В.Н., Козлов С.В., Кочурова Е.В. Способ качественной экспресс-диагностики злокачественных новообразований костей верхней и нижней челюстей по содержанию биомаркеров в плазме крови и в ротовой жидкости пациента /Патент RU 2521196 C1 (Роспатент) “Изобретения. Полезные модели» № 18.
  21. Johnson P.J., Lo Y.M. Plasma nucleic acids in the diagnosis and management of malignant disease. Clin. Chem. 2002; 48: 1186-93.
  22. Li Y., St. John M.A., Zhou X. et al. Salivary transcriptome diagnostics for oral cancer detection. Clin. Cancer Res. 2004; 10: 8442-50.
  23. Neves A.F., Araujo T.G., Biase W.K. et al. Combined analysis of multiple mRNA markers by RT-PCR assay for prostate cancer diagnosis. Clin. Biochem. 2008; 41: 1191-8.
  24. Honma H., Kanda T., Ito H. et al. Squamous cell carcinoma-antigen messenger RNA level in peripheral blood predicts recurrence after resection in patients with esophageal squamous cell carcinoma. Surgery. 2006; 139: 678-85.
  25. Voorzanger-Rousselot N., Goehrig D., Journe F. et al. Increased Dickkopf-1 expression in breast cancer bone metastases. Br. J. Cancer. 2007; 97: 964-70.
  26. El-Abd E., El-Tahan R., Fahmy L. et al. Serum metastasin mRNA is an important survival predictor in breast cancer. Br. J. Biomed Sci. 2008; 65: 90-4.
  27. Ogawa O., Iinuma M., Sato K. et al. Circulating prostate-specific antigen mRNA during radical prostatectomy in patients with localized prostate cancer: with special reference to neoadjuvant hormonal therapy. Urol. Res. 1999; 27: 291-6.
  28. Siddiqua A., Chendil D., Rowland R. et al. Increased expression of PSA mRNA during brachytherapy in peripheral blood of patients with prostate cancer. Urology. 2002; 60: 270-5.
  29. Guo L., Shi W. Salivary biomarkers for caries risk assessment. J. Calif. Dent. Assoc. 2013; 41(2): 107-18.
  30. Filoche S., Wong L., Sissons C.H. Oral biofilms: emerging concepts in microbial ecology. J. Dent. Res. 2010; 89(1): 8-18.
  31. Mithra N.H., Bhat R., Punja А., Shety C. Corelation betwen Dental Caries and Salivary Albumin in Adult Indian Population - An In Vivo Study. Brit. J. Med. Res. 2014; 25 (4): 4238-424.
  32. Martins C., Buczynski A.K., Maia L.C., Siqueria W.L., Barbosa De Araujo Castro G.F. Salivary protiens as a biomarker for dental caries-a systematic review. J. Dent. 2013; 41(1): 2-8.
  33. Кочурова Е.В., Козлов С.В., Николенко В.Н., Гуйтер О.С. Влияние вида конструкции стоматологического протеза на уровень биомаркеров ротовой жидкости у пациентов с приобретенными дефектами челюстно-лицевой области. Российский стоматологический журнал. 2013; 5: 32-4.

Copyright (c) 2014 Eco-Vector


 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies